Abstract
(Abstracted from Fertil Steril 2019;112:82–88) Blastocyst biopsy as a means of preimplantation genetic testing (PGT) continues to increase in popularity and might provide a greater number of viable cells per biopsy compared with cleavage-stage biopsy. The increased number of testable cells enables the application of comprehensive chromosome screening modalities including next-generation sequencing, as well as the combination of multiple genetic tests.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
